These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18950385)

  • 1. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
    Chen YY; Huang MC; Wu KC
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
    Saitis M; Papazisis G; Katsigiannopoulos K; Kouvelas D
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):624. PubMed ID: 18950388
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine-associated increase of triglycerides: a case report.
    Zink M; Marquardt L; Sartorius A
    J Clin Psychiatry; 2010 Nov; 71(11):1554-5. PubMed ID: 21114954
    [No Abstract]   [Full Text] [Related]  

  • 4. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L; Balci V; Akyildiz U
    J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    Jagadheesan K; Muirhead D
    Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
    [No Abstract]   [Full Text] [Related]  

  • 6. Amisulpride-induced tardive dystonia: a case report.
    Guriz O; Ekinci AE; Orsel S; Ekinci O
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride treatment for clozapine-induced sialorrhea.
    Praharaj SK; Sarkar S; Sinha VK
    J Clin Psychopharmacol; 2009 Apr; 29(2):189-90. PubMed ID: 19512987
    [No Abstract]   [Full Text] [Related]  

  • 9. Quetiapine combined with amisulpride in schizophrenic patients with insufficient responses to quetiapine monotherapy.
    Englisch S; Enning F; Grosshans M; Marquardt L; Waltereit R; Zink M
    Clin Neuropharmacol; 2010; 33(5):227-9. PubMed ID: 20838213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of tardive dyskinesia in a patient taking amisulpride.
    Masdrakis VG; Papadimitriou GN; Papageorgiou C; Kouzoupis A; Giailoglou D; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):586-7. PubMed ID: 17196725
    [No Abstract]   [Full Text] [Related]  

  • 11. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary incontinence associated with amisulpride.
    Mendhekar D; Lohia D
    World J Biol Psychiatry; 2009; 10(4 Pt 3):1045-6. PubMed ID: 18609424
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 14. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
    Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
    Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient hyperproinsulinemia during treatment with clozapine and amisulpride.
    Rettenbacher MA; Hummer M; Fleischhacker WW; Lechleitner M
    J Clin Psychiatry; 2004 Jun; 65(6):878-9. PubMed ID: 15291669
    [No Abstract]   [Full Text] [Related]  

  • 17. Amisulpride therapeutic dose-induced asymptomatic bradycardia.
    Prikryl R; Ustohal L; Prikrylova-Kucerova H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):290. PubMed ID: 20965224
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride.
    Opgen-Rhein C; Neuhaus AH; Dettling M
    J Clin Psychopharmacol; 2007 Feb; 27(1):92-3. PubMed ID: 17224723
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of quetiapine withdrawal syndrome in a geriatric patient.
    Kohen I; Kremen N
    World J Biol Psychiatry; 2009; 10(4 Pt 3):985-6. PubMed ID: 17965985
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.